| human | Q5 |
| P496 | ORCID iD | 0000-0002-4445-590X |
| P3829 | Publons author ID | 2493534 |
| P1053 | ResearcherID | K-5301-2014 |
| P735 | given name | Ana Isabel | Q51765304 |
| Ana Isabel | Q51765304 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q46677464 | Adipose tissue loss in adjuvant arthritis is associated with a decrease in lipogenesis, but not with an increase in lipolysis |
| Q45126768 | Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats |
| Q59708847 | Anti-tumor necrosis factor agent PEG-sTNFRI improves the growth hormone/insulin-like growth factor-I system in adjuvant-induced arthritic rats |
| Q59708884 | Arthritis-induced increase in serum levels of IGF-binding protein-3 in rats is secondary to the decrease in its proteolytic activity |
| Q59708920 | Chronic inflammation inhibits GH secretion and alters the serum insulin-like growth factor system in rats |
| Q59708802 | Comparison of the effects of the n-3 polyunsaturated fatty acid eicosapentaenoic and fenofibrate on the inhibitory effect of arthritis on IGF1 |
| Q46585158 | Cyclooxygenase-2 [corrected] activation by endotoxin mediates the decrease in IGF1, but not in IGFBP3, [corrected] gene expression in the liver |
| Q46087028 | Cyclooxygenase-2 inhibition reverts the decrease in adiponectin levels and attenuates the loss of white adipose tissue during chronic inflammation |
| Q36017471 | D-TRP(8)-γMSH Prevents the Effects of Endotoxin in Rat Skeletal Muscle Cells through TNFα/NF-KB Signalling Pathway |
| Q28854319 | Dexamethasone administration attenuates the inhibitory effect of lipopolysaccharide on IGF-I and IGF-binding protein-3 in adult rats |
| Q44671951 | Effect of inducible nitric oxide synthase inhibition by aminoguanidine on insulin-like growth factor binding protein-3 in adjuvant-induced arthritic rats |
| Q49172529 | Effects of catecholamine synthesis inhibitors and adrenergic receptor antagonists on restraint-induced LH release |
| Q48363264 | Effects of endotoxin lipopolysaccharide administration on the somatotropic axis |
| Q43278882 | Eicosapentaenoic acid attenuates arthritis-induced muscle wasting acting on atrogin-1 and on myogenic regulatory factors |
| Q45151341 | Endotoxin administration increases hypothalamic somatostatin mRNA through nitric oxide release |
| Q47582973 | Endotoxin at low doses stimulates pituitary GH whereas it decreases IGF-I and IGF-binding protein-3 in rats. |
| Q59708876 | Endotoxin decreases serum IGFBP-3 and liver IGFBP-3 mRNA: comparison between Lewis and Wistar rats |
| Q48281187 | Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation |
| Q59708806 | Fenofibrate, a PPARα agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy |
| Q44006824 | GH administration and renal IGF-I system in arthritic rats. |
| Q46911942 | GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia |
| Q59708869 | Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle |
| Q59708916 | IGF-I and IGF-I-binding proteins in rats with adjuvant-induced arthritis given recombinant human growth hormone |
| Q54741209 | IGF-I system, atrogenes and myogenic regulatory factors in arthritis induced muscle wasting. |
| Q43517995 | Inactivation of Kupffer cells by gadolinium administration prevents lipopolysaccharide-induced decrease in liver insulin-like growth factor-I and IGF-binding protein-3 gene expression. |
| Q44586422 | NO plays a role in LPS-induced decreases in circulating IGF-I and IGFBP-3 and their gene expression in the liver |
| Q44688118 | Naltrexone does not reverse the inhibitory effect of chronic restraint on gonadotropin secretion in the intact male rat. |
| Q54579297 | Nitric oxide production by hepatocytes contributes to the inhibitory effect of endotoxin on insulin-like growth factor I gene expression. |
| Q59708940 | Restraint-Induced Changes in Serum Luteinizing Hormone, Prolactin, Growth Hormone and Corticosterone Levels in Rats: Effect of Superior Cervical Ganglionectomy |
| Q59708933 | Short and long restraint differentially affect humoral and cellular immune functions |
| Q44803921 | Systemic IGF-I administration attenuates the inhibitory effect of chronic arthritis on gastrocnemius mass and decreases atrogin-1 and IGFBP-3. |
| Q48117321 | Systemic α-melanocyte-stimulating hormone administration decreases arthritis-induced anorexia and muscle wasting |
| Q54139890 | The decrease in hepatic IGF-I gene expression in arthritic rats is not associated with modifications in hepatic GH receptor mRNA. |
| Q59708925 | The effect of cyclosporine administration on growth hormone release and serum concentrations of insulin-like growth factor-I in male rats |
| Q44667798 | The inhibition of inducible nitric oxide synthase reverts arthritic-induced decrease in pituitary growth hormone mRNA but not in liver insulin-like growth factor I mRNA expression. |
| Q36706589 | The melanocortin receptor type 3 agonist d-Trp(8)-γMSH decreases inflammation and muscle wasting in arthritic rats |
| Q54574421 | Tumour necrosis factor blockade did not prevent the increase of muscular muscle RING finger-1 and muscle atrophy F-box in arthritic rats. |
| Q34247135 | αMSH blunts endotoxin-induced MuRF1 and atrogin-1 upregulation in skeletal muscle by modulating NF-κB and Akt/FoxO1 pathway |
Search more.